Atlas Trials

Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis

Clinical trial NCT01541670 · TERMINATED

Trial details

NCT number
NCT01541670
Sponsor
Baxalta now part of Shire
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2011-11-28
Primary completion
2012-12-31
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.